New gene-editing treatment extends lifespan in mice with prion disease

Researchers at the Broad Institute of MIT and Harvard have developed a gene-editing treatment for prion disease that extends lifespan by about 50 percent in a mouse model of the fatal neurodegenerative condition.

Urine Test Accurately Detected High-Grade Prostate Cancer

A new 18-gene urine test demonstrated higher diagnostic accuracy for high-grade prostate cancer compared with existing biomarker tests, a study showed. In applying a testing

April 19, 2024

Emergent wins $235.8m US defence contract for Anthrax vaccine

Share this article Emergent has several contracts with US government agencies for vaccines and therapeutics for various infectious diseases. Image Credit: Africa Studio / Shutterstock.

January 12, 2024

Viatris Inc Patent: Nasal Spray Method for Treating Dry Eye Disease

Share this article According to GlobalData’s company profile on Viatris, Cancer treatment biomarkers was a key innovation area identified from patents. Viatris‘s grant share as

April 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.